Yes. Insulin resistance can begin before your A1C reaches the prediabetes range.
That’s because your body may compensate for reduced insulin sensitivity by producing more insulin. For a period of time, that extra insulin can keep blood glucose within a relatively normal range even though your metabolism is already working harder to maintain it.
This is where the difference between fasting insulin and hemoglobin A1C, or HbA1c, becomes important.
A1C tells you about your average blood glucose over roughly the previous three months. Fasting insulin gives a snapshot of how much insulin is circulating after an overnight fast. They measure different parts of glucose metabolism, and neither should be interpreted in isolation.
If your A1C is “normal,” that’s useful information. But it does not automatically prove that your insulin sensitivity is optimal.
Here’s what that means, why it matters, and what to consider if you’re trying to identify metabolic dysfunction before it progresses to prediabetes or type 2 diabetes.
What Is Insulin Resistance?
Insulin is a hormone produced primarily by beta cells in the pancreas. One of its major jobs is helping regulate blood glucose.
After you eat, carbohydrates are broken down into glucose. As glucose enters your bloodstream, your pancreas releases insulin. Insulin helps tissues such as muscle and fat take up glucose and also influences how the liver stores and releases glucose.
When your cells become less responsive to insulin, the body may need to produce more insulin to achieve the same effect.
That is insulin resistance.
Early in this process, the pancreas can often compensate.
Imagine that your cells normally respond when insulin “knocks” once.
As insulin sensitivity declines, the body may need to knock three, four, or five times harder to produce the same response.
Blood glucose may still look normal because the pancreas is increasing insulin output.
This compensatory phase helps explain how metabolic dysfunction can develop before standard glucose markers cross diagnostic thresholds.
Research has long demonstrated that abnormalities in insulin sensitivity can exist before overt abnormalities in glucose tolerance appear.
What Does A1C Measure?
Hemoglobin A1C measures the percentage of hemoglobin in your red blood cells that has glucose attached to it.
Because red blood cells circulate for several months, A1C provides an estimate of average blood glucose over approximately the previous three months. More recent glucose levels influence the result more heavily than glucose levels from several months earlier.
According to current diagnostic criteria:
| A1C | Classification |
|---|---|
| Below 5.7% | Normal |
| 5.7% to 6.4% | Prediabetes |
| 6.5% or higher | Diabetes* |
*In the absence of unequivocal hyperglycemia, abnormal diagnostic results generally require confirmation.
A1C is valuable because it is convenient, does not require fasting, and reflects longer-term glucose exposure instead of one moment in time.
But there is an important distinction:
A1C measures glucose exposure. It does not directly measure how much insulin your body needed to maintain that glucose level.
That distinction is central to understanding early insulin resistance.
What Does Fasting Insulin Measure?
A fasting insulin test measures the insulin circulating in your blood after a period without caloric intake, typically alongside fasting glucose.
For example, consider two hypothetical people.
Person A
- Fasting glucose: 88 mg/dL
- A1C: 5.2%
- Relatively low fasting insulin
Person B
- Fasting glucose: 88 mg/dL
- A1C: 5.2%
- Substantially higher fasting insulin
Their glucose markers look identical.
But Person B may be requiring considerably more insulin to maintain the same fasting glucose.
That difference can provide useful metabolic context.
However, fasting insulin comes with an important limitation that often gets ignored online.
There Is No Universally Accepted Fasting Insulin Cutoff for Insulin Resistance
Unlike A1C and fasting glucose, fasting insulin does not have universally standardized diagnostic thresholds for insulin resistance or prediabetes.
Insulin assays can differ between laboratories and methods, and expert laboratory recommendations do not currently endorse routine insulin testing as a primary diagnostic test for diabetes or cardiovascular risk in the general population.
That means a fasting insulin result should not be interpreted as:
“Below this number you are healthy, and above this number you have insulin resistance.”
Human biology has once again refused to fit neatly inside an Instagram infographic.
Fasting insulin is better interpreted alongside:
- Fasting glucose
- A1C
- Triglycerides
- High-density lipoprotein cholesterol, or HDL
- Waist circumference
- Blood pressure
- Body composition
- Family history
- Physical activity
- Medications
- Symptoms and medical history
- In some cases, an oral glucose tolerance test
The trend over time may also be more informative than one isolated result.
Fasting Insulin vs. A1C: What Is the Difference?
The easiest way to understand these tests is to recognize that they answer different questions.
A1C asks:
How much glucose has been circulating in the blood over the last several months?
Fasting insulin asks:
How much insulin is circulating right now in a fasting state?
A1C looks primarily at the glucose side of metabolism.
Fasting insulin provides information about the hormonal response helping regulate that glucose.
This creates an important possibility:
Your A1C can remain normal while insulin levels increase.
When insulin sensitivity begins to decline, pancreatic beta cells may increase insulin secretion to compensate.
For a while, the increased insulin response may successfully maintain normal glucose.
A1C may therefore remain below 5.7%.
Eventually, in people who progress toward type 2 diabetes, compensation may become insufficient. Glucose starts rising more consistently and may cross into the prediabetes range.
Prediabetes is therefore not necessarily the first moment metabolic dysfunction began.
It is the point at which glucose has crossed established diagnostic criteria.
Can You Have Insulin Resistance With a Normal A1C?
Yes.
A normal A1C indicates that your average glucose has not crossed the established threshold for prediabetes.
It does not directly measure insulin sensitivity.
This matters particularly when several other metabolic risk factors are present.
For example, a person may have:
- A1C of 5.4%
- Increasing waist circumference
- Elevated triglycerides
- Low HDL cholesterol
- Rising fasting insulin
- Family history of type 2 diabetes
- Sedentary lifestyle
That person technically does not meet A1C criteria for prediabetes.
But dismissing the entire metabolic picture because the A1C has not reached 5.7% would miss potentially useful information.
The American Diabetes Association recommends diabetes screening beginning no later than age 35 for adults generally, with earlier testing considered when overweight, obesity, or additional risk factors are present.
Why Glucose Can Stay Normal During Early Insulin Resistance
Think of glucose control as a balancing act between several organs and hormones.
Your pancreas secretes insulin.
Your liver regulates glucose production and storage.
Skeletal muscle accounts for a major portion of insulin-stimulated glucose disposal after meals.
Fat tissue also responds to insulin and influences metabolic signaling.
During early insulin resistance, these tissues respond less effectively to insulin.
The pancreas compensates by increasing insulin secretion.
As long as the pancreas can produce enough insulin to compensate, blood glucose may remain relatively controlled.
This is sometimes described as compensatory hyperinsulinemia.
The precise relationship between hyperinsulinemia and insulin resistance is more complicated than the simple idea that insulin resistance always occurs first. Research continues to examine whether excessive insulin secretion can itself contribute to worsening insulin resistance in certain contexts.
For practical purposes, the key takeaway remains:
Glucose and insulin regulation can become abnormal before A1C reaches the diagnostic range for prediabetes.
What About Fasting Glucose?
Fasting glucose adds another useful piece of information.
Standard diagnostic ranges include:
| Fasting Plasma Glucose | Classification |
| Below 100 mg/dL | Normal |
| 100 to 125 mg/dL | Prediabetes |
| 126 mg/dL or higher | Diabetes* |
A fasting plasma glucose test requires at least eight hours without caloric intake.
Just like A1C, however, fasting glucose tells you about glucose rather than directly measuring insulin sensitivity.
Someone could potentially need progressively more insulin to keep fasting glucose at 90 mg/dL.
Looking only at glucose would not reveal the amount of insulin required to maintain that number.
What Is HOMA-IR?
Some clinicians and researchers combine fasting insulin and fasting glucose into an estimate called the Homeostatic Model Assessment of Insulin Resistance, commonly abbreviated HOMA-IR.
A commonly used calculation when glucose is reported in mg/dL is:
HOMA-IR = fasting insulin × fasting glucose ÷ 405
For example:
- Fasting insulin: 10 µIU/mL
- Fasting glucose: 90 mg/dL
Calculation:
10 × 90 = 900
900 ÷ 405 = 2.22
HOMA-IR can help estimate insulin resistance in research and some clinical settings.
But once again, interpretation matters.
There is no single HOMA-IR cutoff that accurately diagnoses insulin resistance in every person.
Values can differ based on population, ethnicity, age, laboratory methods, metabolic status, and the insulin assay being used.
The reference method for directly assessing insulin sensitivity in research is the hyperinsulinemic-euglycemic clamp, but that procedure is complex and impractical for routine outpatient screening.
HOMA-IR is therefore best viewed as an estimate, not a standalone diagnosis.
Why A1C Should Still Be Part of the Picture
None of this means A1C is a bad test.
Quite the opposite.
A1C is well standardized, widely available, convenient, and strongly established for screening and diagnosing prediabetes and diabetes.
It simply answers a different question than fasting insulin.
A complete metabolic assessment may use several markers because each provides a different view.
Think of A1C as the average score over a season.
Fasting glucose is today’s score.
Fasting insulin may offer context about how hard your body is working behind the scenes to keep those scores where they are.
No single marker tells the entire story.
When A1C Can Be Misleading
Another reason clinicians look at multiple markers is that A1C can be affected by conditions that change red blood cell lifespan or hemoglobin.
Examples include:
- Significant blood loss
- Iron-deficiency anemia
- Certain hemoglobin variants
- Blood transfusions
- Hemodialysis
- Erythropoietin treatment
- Some forms of kidney or liver disease
In these situations, A1C may be higher or lower than expected relative to actual glucose levels.
This becomes especially important when A1C does not match fasting glucose, home glucose readings, or other clinical findings.
Different tests can also occasionally disagree during early stages of abnormal glucose metabolism. NIDDK notes that one test may identify diabetes or prediabetes when another does not, which is one reason abnormal diagnostic findings are generally confirmed.
Early Signs That May Justify a Deeper Metabolic Evaluation
Insulin resistance often does not produce a clear, specific symptom.
That is exactly why relying on symptoms alone can be misleading.
Still, a broader metabolic evaluation may be appropriate when risk factors start accumulating, including:
- Increasing abdominal body fat
- Elevated triglycerides
- Low HDL cholesterol
- Elevated blood pressure
- History of gestational diabetes
- Polycystic ovary syndrome
- Strong family history of type 2 diabetes
- Overweight or obesity
- Low physical activity
- Metabolic dysfunction-associated steatotic liver disease
- Rising fasting glucose or A1C over several years
The important concept is trajectory.
An A1C moving from 4.9% to 5.2% to 5.5% over several years tells a different story than an A1C that has remained stable at 5.2%.
The same applies to fasting glucose, insulin, triglycerides, waist circumference, and body composition.
One number is a snapshot.
Several markers measured over time create a movie.
What Tests Can Help Evaluate Metabolic Health?
Depending on a person’s health history and risk factors, a clinician may consider some combination of:
1. A1C
Provides an estimate of average blood glucose over approximately three months.
2. Fasting glucose
Shows blood glucose after an overnight fast.
3. Fasting insulin
May provide additional information about insulin demand, although it is not a standardized diagnostic test for insulin resistance.
4. Lipid panel
Triglycerides and HDL cholesterol can provide additional clues about metabolic health.
5. Comprehensive metabolic panel
Helps assess glucose along with liver, kidney, and electrolyte markers.
6. Oral glucose tolerance test
An oral glucose tolerance test, or OGTT, measures the body’s glucose response after consuming a standardized glucose load.
A person can have relatively normal fasting glucose while showing abnormal glucose regulation after a challenge.
7. Blood pressure and waist circumference
Metabolic health is bigger than blood sugar.
Changes in abdominal adiposity, blood pressure, triglycerides, glucose regulation, and insulin sensitivity frequently overlap.
The goal is not to order every laboratory test available.
The goal is to choose tests that answer useful clinical questions.
Can Insulin Resistance Be Improved Before Prediabetes Develops?
Often, metabolic risk can be meaningfully improved before type 2 diabetes develops.
That is exactly why identifying risk earlier can matter.
Lifestyle intervention has some of the strongest evidence available.
In the landmark Diabetes Prevention Program, people at high risk for type 2 diabetes who participated in an intensive lifestyle program reduced diabetes incidence by 58% compared with placebo during the original trial period.
Current ADA guidance continues to emphasize lifestyle strategies for people at high risk of progressing to type 2 diabetes.
Important areas include:
Build and maintain muscle
Skeletal muscle is a major site of glucose disposal.
Resistance training and regular physical activity can support insulin sensitivity while helping preserve lean mass.
Increase daily movement
You do not need to turn every workout into punishment.
Brisk walking, cycling, swimming, recreational activity, and other forms of moderate-intensity exercise can all contribute.
For adults with prediabetes, ADA guidance supports working toward at least 150 minutes per week of moderate-intensity physical activity, such as brisk walking.
Address excess body fat when appropriate
For people carrying excess adiposity, losing even a modest amount of body weight can produce meaningful metabolic improvements.
Current ADA guidance for people with prediabetes commonly targets approximately 5% to 7% weight loss from baseline when weight loss is appropriate.
Improve dietary quality
There is no single “insulin resistance diet” that works for everyone.
A practical nutrition strategy typically emphasizes:
- Adequate protein
- Fiber-rich vegetables
- Minimally processed carbohydrate sources
- Healthy fats
- Appropriate total calorie intake
- Fewer highly refined foods
- Portion sizes matched to energy needs
Nutrition should also be realistic enough to follow for more than twelve heroic days in January.
Protect sleep and recovery
Metabolic health is affected by more than food.
Sleep, physical activity, body composition, medications, genetics, stress, and other health conditions all influence glucose regulation.
For someone exercising regularly and eating reasonably well but still seeing worsening metabolic markers, the next move should usually be a deeper evaluation rather than simply cutting another 500 calories.
Is Fasting Insulin Better Than A1C?
Not exactly.
This is the wrong way to frame the comparison.
A1C and fasting insulin measure different things.
A1C has established diagnostic thresholds and is widely used to screen for prediabetes and diabetes.
Fasting insulin does not have a universally accepted diagnostic cutoff and is not currently recommended as a routine standalone screening test for diabetes.
But fasting insulin may provide additional context in selected patients when interpreted with fasting glucose, body composition, lipids, medical history, and other metabolic markers.
So the better question is:
What combination of information gives the clearest picture of this person’s metabolic health?
That answer will vary from person to person.
“My A1C Is Normal. Should I Still Be Concerned?”
A normal A1C is reassuring.
It should not be ignored or dismissed simply because someone on social media decided everyone with a fasting insulin above their favorite number is metabolically doomed.
At the same time, normal A1C does not guarantee perfect insulin sensitivity.
If your:
- A1C is rising
- Fasting glucose is increasing
- Triglycerides are worsening
- Waist circumference is increasing
- Family history is strong
- Body composition is changing
- Other cardiometabolic risk factors are accumulating
then looking more closely may make sense.
The objective should not be to hunt for disease where none exists.
It should be to recognize patterns early enough that you still have options.
Frequently Asked Questions
Can fasting insulin be high if A1C is normal?
Yes. In some people, higher insulin secretion may compensate for decreased insulin sensitivity and help keep glucose within a normal range. However, fasting insulin varies considerably and should not be used alone to diagnose insulin resistance.
Does a normal A1C mean I am not insulin resistant?
No. A normal A1C means your average blood glucose is below the established prediabetes threshold. A1C does not directly measure insulin sensitivity.
What A1C level is considered prediabetes?
An A1C between 5.7% and 6.4% meets the laboratory range used to identify prediabetes. An A1C of 6.5% or higher meets one criterion for diabetes and generally requires confirmation when unequivocal hyperglycemia is absent.
What fasting glucose level is considered prediabetes?
A fasting plasma glucose of 100 to 125 mg/dL is considered impaired fasting glucose and falls within the prediabetes range.
What fasting insulin level means insulin resistance?
There is currently no universally accepted fasting insulin cutoff that diagnoses insulin resistance across all people and laboratory methods. Interpretation should account for the laboratory assay and the rest of the person’s metabolic picture.
Is HOMA-IR more useful than fasting insulin?
HOMA-IR combines fasting glucose and fasting insulin to estimate insulin resistance and can provide useful information in research and selected clinical situations. However, it also lacks a universally applicable diagnostic threshold.
Can insulin resistance be reversed?
Insulin sensitivity can often improve substantially with changes in physical activity, body composition, nutrition, sleep, weight management when appropriate, and treatment of contributing medical conditions. Whether someone would describe this as “reversing” insulin resistance depends on the underlying cause and clinical situation.
The Bottom Line
Insulin resistance can begin before A1C reaches the prediabetes range.
A1C measures average glucose exposure.
Fasting glucose measures blood glucose at one fasting point in time.
Fasting insulin provides information about circulating insulin during that fasting state.
Looking at these markers together can sometimes reveal a more complete metabolic picture than relying on A1C alone.
But more testing is not automatically better testing.
Fasting insulin and HOMA-IR do not have universally accepted diagnostic cutoffs, which means they need clinical context.
The goal is not to chase an arbitrary “optimal” number.
The goal is to understand how efficiently your body is regulating glucose, identify meaningful risk patterns, and intervene appropriately before those patterns become bigger problems.
At 1st Optimal, we take a comprehensive approach to metabolic and functional health by looking at your laboratory data alongside your symptoms, health history, body composition, nutrition, activity, hormones, and long-term goals.
If your labs are technically “normal” but your health, weight, energy, or metabolic markers are moving in the wrong direction, a deeper evaluation may help identify what is actually changing.
Educational only, not medical advice. Laboratory testing and treatment decisions should be individualized with a qualified healthcare professional.
References:
- American Diabetes Association. Standards of Care in Diabetes, 2026: Diagnosis and Classification of Diabetes. Current ADA guidance includes established A1C and plasma glucose criteria for identifying prediabetes and diabetes.
- National Institute of Diabetes and Digestive and Kidney Diseases. The A1C Test & Diabetes. Provides information on A1C interpretation, diagnostic ranges, limitations, and factors that may affect results.
- Sacks DB, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Routine insulin or proinsulin measurement is not recommended as a primary screening method in most people at risk for diabetes or cardiovascular disease.
- Staten MA, et al. Insulin Assay Standardization. Describes challenges in standardizing insulin assays and comparing insulin measurements across laboratory methods.
- Knowler WC, et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. The Diabetes Prevention Program demonstrated a 58% reduction in diabetes incidence with intensive lifestyle intervention during the initial trial.
